Theraclion SA (EPA: ALTHE)

Market Cap	14.36M
Revenue (ttm)	1.28M
Net Income (ttm)	-3.56M
Shares Out	46.03M
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,518
Open	0.340
Previous Close	0.312
Day's Range	0.314 - 0.340
52-Week Range	0.286 - 0.680
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 27, 2024

About Theraclion

Theraclion SA designs and markets high-tech therapeutic ultrasound equipment. It offers SONOVEIN, a robotic solution for non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment and protects the patient’s skin and optimizes the image quality. Theraclion SA was incorporated in 2004 and is based in Malakoff, France.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 29
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALTHE

Financial Performance

In 2023, Theraclion's revenue was 1.82 million, an increase of 47.49% compared to the previous year's 1.24 million. Losses were -3.68 million, -25.97% less than in 2022.